Atlas Trials

NEoadjuvant Gefitinib fOllowed by Surgery and gefiTinib In unresectAble sTage III NSCLC With EGFR Mutations.

Clinical trial NCT02347839 · WITHDRAWN

Trial details

NCT number
NCT02347839
Sponsor
Sun Yat-sen University
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Lung Cancer
Start date
2016-01-01
Primary completion
2025-01-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.